The high rate of side effects from oral immunotherapy in the NIH trial explains the superiority of omalizumab. A clinical ...
Project Optimus seeks to transform how doses are selected and optimised in oncology drug development. As this initiative ...
Mind Medicine (MindMed) Inc. ( NASDAQ: MNMD) Q4 2024 Earnings Conference Call March 6, 2025 8:00 AM ET Stephanie Fagan - Chief Corporate Affairs Officer Rob Barrow - CEO Dan Karlin - CMO ...
In the medical device industry, usability plays a critical role in ensuring the safety and effectiveness of highly complex ...
Podcast: This episode explores how non-representative samples can influence study conclusions and highlights solutions for strengthening study validity.
Posters presented at the Association of Cancer Care Centers opening session covered initiatives to boost clinical trial ...